SMTL ID : 5lrq.1

BRD4 in complex with ERK5 inhibitor XMD8-92

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.70 Å

Oligo State

monomer

Ligands

1 x 4WG: 2-{[2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5,11-dimethyl-5,11-dihydro-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one(Non-covalent)

4WG.1: 11 residues within 4Å: Chain A: W.61, P.62, F.63, Q.65, V.67, L.72, L.74, C.116, Y.119, N.120, I.126 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.72, A:L.74, A:Y.119 Hydrogen bonds: A:Q.65, A:N.120 pi-Stacking: A:W.61

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Myers, S.M. et al., Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38 alpha and BRD4. Eur.J.Med.Chem. (2019)

Release Date

2017-08-30

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 4